Furthermore, its downregulation in leukemia cell lines with ALL1-inactivating chromosomal rearrangements was indicative of the oncogenic property of PITX2/ARP1 in leukemia[306], possibly in conjunction with hypermethylation of its promoter, observed in acute myeloid leukemia[307]. The gene discussed is PITX2; the disease is acute myeloid leukemia.